Computational Modeling of Clinically Approved Alkylating Agents Against Epidermal and Fibroblast Growth Factor Receptors: A Step Toward Liver Cancer Therapeutics. Pjmcr [Internet]. 2025 Dec. 24 [cited 2026 Aug. 29];4(4):1970-87. Available from: https://pakjmcr.com/index.php/1/article/view/394